Mannatech, Incorporated ( MTEX) Stock. Should you Buy or Sell? $ 20.16
-0.17 (-0.85 %)
Mannatech, Incorporated AnalysisUpdated on 10-09-2022
|Volume Avg.||$7.21 thousand|
|Market Cap||$39.17 M|
|52 Week Range||$15.49 - $43.1|
Mannatech, Incorporated opened the day at $20.16 which is -0.85 % on yesterday's close. Mannatech, Incorporated has a 52 week high of $43.1 and 52 week low of $15.49, which is a difference of $27.61. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $39.17 M and total net profit is $159762000 which means the company is trading at 0.25 times profit to market capitalization. Theoretically, if you were to buy Mannatech, Incorporated for $39.17 M, it would take 15 years to get your money back. Mannatech, Incorporated are in the Household & Personal Products space which will have a sweet spot and industry standard for net profit multiples.
Mannatech, Incorporated Stock Forecast - Is Mannatech, Incorporated a Buy or Sell?
|DCF Score||Strong Buy|
|PE Score||Strong Buy|
|PB Score||Strong Buy|
|Overall Recommendation||Strong Buy|
Growth and Value
|Net Profit Margin||0.072|
Valuing Mannatech, Incorporated
|Price Book Value Ratio||1.840||Price To Book Ratio||1.840|
|Price To Sales Ratio||0.209||Price Earnings Ratio||2.879|
How liquid is Mannatech, Incorporated
|Debt Ratio||0.637||Debt Equity Ratio||1.758|
|Long Term Debt To Capitalization||0.180||Total Debt To Capitalization||0.241|
Latest news about Mannatech, Incorporated
Mannatech, a multi-level-marketing company, tends to announce a large tender offer before its annual June shareholders' meeting; A new large tender offer may be launched shortly;
Mannatech is a little-known wellness, nutrition and dietary supplement outfit with an extremely low valuation vs. peers. Pandemic forces in the economy have resulted in strong free cash flow generation, with much better final margins on sales.
It's a great time to look beyond the big name pharmaceutical stocks and look for great niche players with big futures. The post 7 Top-Rated Pharmaceutical Stocks To Invest in for October appeared first on InvestorPlace.
Mannatech Inc (NASDAQ: MTEX) Board of Directors has approved a share repurchase program to acquire up to $1.0 million of its outstanding common stock. The buyback program will begin on September 21, 2021, and ends on the earlier of September 21, 2022, or purchase of $1 mln common stock.
FLOWER MOUND, Texas--(BUSINESS WIRE)--Mannatech, Incorporated (NASDAQ: MTEX), (“Mannatech”), today announced that its Board of Directors has approved a share repurchase program to acquire up to $1.0 million of its outstanding common stock. The authorized repurchases will be made from time to time in the open market, through block trades or in privately negotiated transactions. The timing, volume and nature of share repurchases will be at the discretion of management and dependent on market cond
About Mannatech, Incorporated
Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.